The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis

Nitric Oxide - Biology and Chemistry

Volumn 24, Issue 4, 2011, Pages 199-203

  Hayashi, Toshio ^a   Ina, Koichiro ^a   Maeda, Morihiko ^a   Nomura, Hideki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Elderly; Hormone replacement therapy; Nitric oxide; Osteoporosis; Selective estrogen receptor modulator

Indexed keywords

ADIPONECTIN; CYCLIC GMP; ESTRIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE; NITRATE; NITRIC OXIDE; NITRITE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; JAPANESE; LIPID BLOOD LEVEL; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADIPONECTIN; AGED; BLOOD GLUCOSE; BONE DENSITY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; JAPAN; MEDROXYPROGESTERONE; NITRIC OXIDE; OSTEOPOROSIS; POSTMENOPAUSE; PROSPECTIVE STUDIES; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79956340936     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2011.04.002     Document Type: Article

References (27)

1. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, H. Black, D. Bonds, R. Brunner, R. Brzyski, B. Caan, R. Chlebowski, D. Curb, M. Gass, J. Hays, G. Heiss, S. Hendrix, B.V. Howard, J. Hsia, A. Hubbell, R. Jackson, K.C. Johnson, H. Judd, J.M. Kotchen, L. Kuller, A.Z. LaCroix, D. Lane, R.D. Langer, N. Lasser, C.E. Lewis, J. Manson, K. Margolis, J. Ockene, M.J. O'Sullivan, L. Phillips, R.L. Prentice, C. Ritenbaugh, J. Robbins, J.E. Rossouw, G. Sarto, M.L. Stefanick, L. Van Horn, J. Wactawski-Wende, R. Wallace, S. Wassertheil-Smoller, Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA 291 (2004) 1701-1712. (Pubitemid 38489892)
2. M. Cesari, A.C. Pessina, M. Zanchetta, R. De Toni, A. Avogaro, L. Pedon, F. Dorigatti, G. Maiolino, G.P. Rossi, Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high-risk nondiabetic patients, J. Int. Med. 260 (2006) 474-483.
3. A.T. Gonon, U. Widegren, A. Bulhak, F. Salehzadeh, J. Persson, P.O. Sjöquist, J. Pernow, Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide, Cardiovasc. Res. 78 (2008) 116-122. (Pubitemid 351430967)
4. H. Hansdóttir, Raloxifene for older women: a review of the literature, Clin. Interv. Aging 3 (2008) 45-50.
5. T. Hayashi, T. Esaki, E. Muto, H. Kano, Y. Asai, N.K. Thakur, D. Sumi, M. Jayachandran, A. Iguchi, Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide, Arterioscler. Thromb. Vasc. Biol. 20 (2000) 782-792. (Pubitemid 30151694)
6. T. Hayashi, M. Jayachandran, D. Sumi, N.K. Thakur, T. Esaki, E. Muto, H. Kano, Y. Asai, A. Iguchi, Physiological concentration of 17beta-estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol diet plus balloon catheter injury: role of NO, Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1613-1621. (Pubitemid 30353896)
7. T. Hayashi, H. Kano, D. Sumi, A. Iguchi, I. Ito, H. Endo, The long-term effect of estriol on endothelial function and bone-mineral density in octogenarian women, J. Am. Geriatr. Soc. 50 (2002) 777-778. (Pubitemid 34298775)
8. G.S. Hotamisligil, N.S. Shargill, B.M. Spiegelman, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science 259 (1993) 87-91. (Pubitemid 23036092)
9. K. Hotta, T. Funahashi, N.L. Bodkin, H.K. Ortmeyer, Y. Arita, B.C. Hansen, Y. Matsuzawa, Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys, Diabetes 50 (2001) 1126-1133. (Pubitemid 32374544)
10. V.C. Jordan, SERMs: meeting the promise of multifunctional medicines, J. Natl. Cancer Inst. 99 (2007) 350-356.
11. K. Kublickiene, E. Svedas, B.-M. Landgren, M. Crisby, N. Nahar, H. Nisell, L. Poston, Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators, J. Clin. Endocrinol. Metab. 90 (2005) 6113-6122.
12. R. Li, W.Q. Wang, H. Zhang, X. Yang, Q. Fan, T.A. Christopher, B.L. Lopez, L. Tao, B.J. Goldstein, F. Gao, X.L. Ma, Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity, Am. J. Physiol. Endocrinol. Metab. 293 (2007) E1703-E1708. (Pubitemid 350255122)
13. S. Maeda, T. Tanabe, T. Otsuki, J. Sugawara, M. Iemitsu, T. Miyauchi, S. Kuno, R. Ajisaka, M. Matsuda, Moderate regular exercise increases basal production of nitric oxide in elderly women, Hypertens. Res. 27 (2004) 947-953.
14. Manual of Laboratory Operations. Lipid Research Clinics Program, vol. 1. Lipid and Lipoprotein Analysis. Bethesda, MD, National Heart, Lung, and Blood Institute, National Institutes of Health. DHEW Publication No. (NIH) 1974;75-628.
15. M. Nishimura, Y. Izumiya, A. Higuchi, R. Shibata, J. Qiu, C. Kudo, H.K. Shin, M.A. Moskowitz, N. Ouchi, Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms, Circulation 117 (2008) 216-223.
16. K. Okano, S. Takahashi, K. Yasuda, D. Tokinaga, K. Imai, M. Koga, Using microparticle labeling and counting for attomole-level detection in heterogeneous immunoassay, Anal. Biochem. 202 (1992) 120-125.
17. H. Ruan, N. Hacohen, T.R. Golub, L. Van Parijs, H.F. Lodish, Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory, Diabetes 51 (2002) 1319-1336. (Pubitemid 34826596)
18. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, J. Ockene, Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA 288 (2002) 321-333. (Pubitemid 34761611)
19. K. Shimada, T. Miyazaki, H. Daida, Adiponectin and atherosclerotic disease, Clin. Chim. Acta. 344 (2004) 1-12. (Pubitemid 38626132)
20. D. Sumi, T. Hayashi, M. Jayachandran, A. Iguchi, Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor alpha through estrogen receptor mediated system, Life Sci. 69 (2001) 1651-1660. (Pubitemid 32800644)
21. H. Tapiero, G.N. Ba, K.D. Tew, Estrogens and environmental estrogens, Biomed. Pharmacother. 56 (2002) 36-44.
22. T. Tsunekawa, T. Hayashi, Y. Suzuki, H. Matsui-Hirai, H. Kano, A. Fukatsu, N. Nomura, A. Miyazaki, A. Iguchi, Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects, Diabetes Care 26 (2003) 285-289. (Pubitemid 36929044)
23. C. Vitale, G. Mercuro, E. Cerquetani, G. Marazzi, R. Patrizi, F. Pelliccia, M. Volterrani, M. Fini, P. Collins, G.M. Rosano, Time since menopause influences the acute and chronic effect of estrogens on endothelial function, Arterioscler. Thromb. Vasc. Biol. 28 (2008) 348-352. (Pubitemid 351161210)
24. B. Walsh, I. Schiff, B. Rosner, L. Greenberg, V. Ravinkar, F.M. Sacks, Effects of post- menopausal estrogen replacement on the concentrations and metabolism of plasma lipoprotein, N. Engl. J. Med. 325 (1991) 1196-1204.
25. C.M. Wong, L.M. Yung, F.P. Leung, S.Y. Tsang, C.L. Au, Z.Y. Chen, X. Yao, C.H. Cheng, C.W. Lau, M. Gollasch, Y. Huang, Raloxifene protects endothelial cell function against oxidative stress, Br. J. Pharmacol. 155 (2008) 326-334.
26. World Health Organization (WHO), World Health Report, WHO, Geneva, 2004.
27. C.C. Wu, S.-J. Chen, M.-H. Yen, Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats, Am. J. Physiol. 275 (1998) H1148-H1157.